靶控输注顺式苯磺酸阿曲库铵在腹腔镜胆囊切除手术中的麻醉效果(3)
[4] 孟美金，许幸.国产顺苯磺酸阿曲库铵临床肌松作用的观察[J].临床麻醉学杂志，2010，26(1)：75-76.
[5] Krieg N，Mazur L，Booij LH，et al. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent Org-NC45 [J]. Acta Anaesthesiol Scand，1980，24：423-425.
[6] 罗高平，龚勇，吴芳，等.缩短顺阿曲库铵起效时间的临床研究[J].西部医学，2009，21(5)：762-763.
[7] Puhringer FK，Heier T，Dodgson M，et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium and vecuronium-induced neuromuscular block in adult and elderly patients [J]. Acta Anaesthesiol Scand，2002，46(4)：364-371.
[8] True CA，Carter PJ. A comparison of tubocurarine，rocuronium，and cisatracurium in the prevention and reduction of succinylcholine in ducedmuscle fasciculations [J]. AANA J，2003，71(1)：23-28.
[9] Fassbender P，Geldner G，Blobner M，et al. Clinical predictors of duration of action of cisatracurium and rocuronium administered longterm [J]. Am J Critcare，2009，18(5)：439-445.
[10] 刘威，闻大翔，杭燕南，等.四种中时效非去极化肌松药组胺释放作用的研究[J].上海第二医科大学学报，2003，7(5)：713-716.
[11] Soukup J，Czeslick E，Bunk S，et al. Cisatracurium in patients with compromised kidney function. Pharmacodynamic and intubation conditions under is of luranenitrous oxide anesthesia [J]. Anaesthesist，1998，47(8)：669-676.
[12] Kopman AF. Pancoronium，gall amine and dtubocurarine compared：is speed of onset inversely related to drug potency [J]. Anesthesiology，1989，70(6)：915-920.
(收稿日期：2012-03-09 本文编辑：张瑜杰), http://www.100md.com(周冠同 温清娴 陈新妹 等)
[5] Krieg N，Mazur L，Booij LH，et al. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent Org-NC45 [J]. Acta Anaesthesiol Scand，1980，24：423-425.
[6] 罗高平，龚勇，吴芳，等.缩短顺阿曲库铵起效时间的临床研究[J].西部医学，2009，21(5)：762-763.
[7] Puhringer FK，Heier T，Dodgson M，et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium and vecuronium-induced neuromuscular block in adult and elderly patients [J]. Acta Anaesthesiol Scand，2002，46(4)：364-371.
[8] True CA，Carter PJ. A comparison of tubocurarine，rocuronium，and cisatracurium in the prevention and reduction of succinylcholine in ducedmuscle fasciculations [J]. AANA J，2003，71(1)：23-28.
[9] Fassbender P，Geldner G，Blobner M，et al. Clinical predictors of duration of action of cisatracurium and rocuronium administered longterm [J]. Am J Critcare，2009，18(5)：439-445.
[10] 刘威，闻大翔，杭燕南，等.四种中时效非去极化肌松药组胺释放作用的研究[J].上海第二医科大学学报，2003，7(5)：713-716.
[11] Soukup J，Czeslick E，Bunk S，et al. Cisatracurium in patients with compromised kidney function. Pharmacodynamic and intubation conditions under is of luranenitrous oxide anesthesia [J]. Anaesthesist，1998，47(8)：669-676.
[12] Kopman AF. Pancoronium，gall amine and dtubocurarine compared：is speed of onset inversely related to drug potency [J]. Anesthesiology，1989，70(6)：915-920.
(收稿日期：2012-03-09 本文编辑：张瑜杰), http://www.100md.com(周冠同 温清娴 陈新妹 等)